LDI - Deputy Director

Gerald Batist, MD FACP

Minda de Gunzburg Professor of Oncology, McGill University
Director, Segal Cancer Centre, Jewish General Hospital
Head, Cancer Axis, Lady Davis Institute
Director, McGill Centre for Translational Research in Cancer, Lady Davis Institute

Tel.: 514-340-8222 ext. 28246

The role of the Deputy Director is to participate, with the Director, in all major decisions involving the LDI. In addition, he frequently represents the LDI at local, national, or international meetings.

Gerald Batist, M.D. is the Minda de Gunzburg Professor of Oncology at McGill University and was University Chair of Oncology for 10 years. He is Deputy Director and leader of the Cancer Axis of the Lady Davis Institute. Dr. Batist led the development of the Segal Cancer Centre, which intimately links research and clinical care and has generated novel treatment models. He co-created the Q-CROC Quebec-wide network and was a co-founder the WIN global consortium for personalized medicine, which is based in Paris. He is a medical oncologist and molecular pharmacologist, whose research focuses on novel drug development and therapeutic resistance. He’s published over 200 papers and book chapters, and shares multiple patents for new chemical entities with novel therapeutic potential. Dr. Batist has achieved significant funding for personalized medicine initiatives, leading large groups in biopsy-driven innovative studies designed to identify molecular signatures of resistance and novel therapeutic targets.